Sanara MedTech Inc.
Calidad de datos: 100%
SMTI
Nasdaq
Manufacturing
Measuring & Analyzing Instruments
$16.53
▼
$0.44
(-2.59%)
Cap. Mercado: 155.66 M
Precio
$16.98
Cap. Mercado
155.66 M
Rango del Día
—
Rango de 52 Semanas
—
Volumen
—
Apertura —
Promedio 50D / 200D
—
Promedio 50D / 200D
—
Quick Summary
Puntos Clave
Revenue grew 43.76% annually over 5 years — strong growth
Debt/Equity of 7.33 — high leverage
Generating 2.16 M in free cash flow
Revenue growth is decelerating — 1Y growth trails 5Y average by 24.79%
Capital efficient — spends only 4.49% of revenue on capex
Interest coverage of 1.08× — tight debt servicing
Crecimiento
Revenue Growth (5Y)
43.76%
Above sector avg (1.82%)
Revenue (1Y)18.97%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Calidad
Return on Equity
-180.81%
Below sector avg (-53.47%)
ROIC8.39%
Net Margin-36.43%
Op. Margin7.08%
Seguridad
Debt / Equity
7.33
Above sector avg (0.30)
Current Ratio1.80
Interest Coverage1.08
Valoración
PE (TTM)
-4.14
Below sector avg (-1.48)
P/B Ratio25.31
EV/EBITDA16.52
Dividend YieldN/A
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Manufacturing (1364 pares)
Comparación con Pares
vs mediana del sector Manufacturing (1364 pares)| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | -4.1 | -1.5 |
| P/B | 25.3 | 1.6 |
| ROE % | -180.8 | -53.5 |
| Net Margin % | -36.4 | -41.5 |
| Rev Growth 5Y % | 43.8 | 1.8 |
| D/E | 7.3 | 0.3 |
Precio Objetivo de Analistas
1 analista
Buy
Actual
$16.53
Objetivo
$36.00
$36.00
$36.00
$36.00
Pronóstico
EPS Futuro
-$1.17
Ingresos Est.
0.0
Estimaciones de Ganancias
| Período | EPS Est. | Ingresos Est. | Analistas |
|---|---|---|---|
| FY2027 | — | 0.0 | — |
| FY2026 |
$0.16
$0.16 – $0.16
|
118.60 M | 1 |
| Período | EPS Est. | Ingresos Est. | Analistas |
|---|---|---|---|
| 2026 Q2 |
$0.02
$0.02 – $0.02
|
29.40 M | 1 |
| 2026 Q1 |
-$0.04
-$0.04 – -$0.04
|
26.90 M | 1 |
Sorpresas de Ganancias
Últimos 4 trimestres
| Trimestre | EPS Est. | EPS Real | Sorpresa |
|---|---|---|---|
| Q42025 | $0.11 | -$0.19 | -272.7% |
| Q32025 | -$0.22 | -$3.52 | -1537.2% |
| Q22025 | -$0.44 | -$0.23 | +47.7% |
| Q12025 | -$0.51 | -$0.41 | +18.8% |
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 18.97% | Revenue Growth (3Y) | 25.96% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 43.76% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 103.12 M | Net Income (TTM) | -37.56 M |
| ROE | -180.81% | ROA | -44.23% |
| Gross Margin | 92.71% | Operating Margin | 7.08% |
| Net Margin | -36.43% | Free Cash Flow (TTM) | 2.16 M |
| ROIC | 8.39% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 7.33 | Current Ratio | 1.80 |
| Interest Coverage | 1.08 | Asset Turnover | 1.21 |
| Working Capital | 13.87 M | Tangible Book Value | -18.55 M |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -4.14 | Forward P/E | N/A |
| P/B Ratio | 25.31 | P/S Ratio | 1.51 |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | 16.52 | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | 1.39% | ||
| Market Cap | 155.66 M | Enterprise Value | 185.81 M |
| Per Share | |||
| EPS (Diluted TTM) | -4.36 | Revenue / Share | 11.25 |
| FCF / Share | 0.24 | OCF / Share | 0.74 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | 4.49% | FCF Conversion | -5.75% |
| SBC-Adj. FCF | -2.84 M | Growth Momentum | -24.79 |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 103.12 M | 86.67 M | 64.99 M | 45.84 M | 24.14 M |
| Net Income | -37.56 M | -9.66 M | -4.30 M | -7.94 M | -7.99 M |
| EPS (Diluted) | -4.36 | -1.14 | -0.52 | — | — |
| Gross Profit | 95.60 M | 78.53 M | 57.14 M | 39.48 M | 21.83 M |
| Operating Income | 7.30 M | -6.72 M | -4.22 M | -12.23 M | -7.38 M |
| EBITDA | — | — | — | — | — |
| R&D Expenses | 5.07 M | 5.70 M | 4.13 M | 3.37 M | 558,704.0 |
| SG&A Expenses | 78.72 M | 76.56 M | 56.99 M | 45.98 M | — |
| D&A | 3.95 M | 4.92 M | 3.68 M | 2.37 M | 596,975.0 |
| Interest Expense | 6.76 M | 3.13 M | 475,783.0 | 284,746.0 | 711.0 |
| Income Tax | 48,380.0 | -48,380.0 | -5.84 M | -5.84 M | — |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 72.94 M | 88.09 M | 73.87 M | 61.04 M | 36.40 M |
| Total Liabilities | 67.01 M | 49.18 M | 29.28 M | 19.32 M | 6.24 M |
| Shareholders' Equity | 5.94 M | 39.40 M | 44.83 M | 41.83 M | 30.64 M |
| Total Debt | 45.97 M | 30.69 M | 9.69 M | — | — |
| Cash & Equivalents | 16.58 M | 15.88 M | 5.15 M | 8.96 M | 18.65 M |
| Current Assets | 33.54 M | 33.31 M | 19.01 M | 20.62 M | 24.61 M |
| Current Liabilities | 18.63 M | 15.29 M | 13.77 M | 12.81 M | 6.02 M |
{"event":"ticker_viewed","properties":{"ticker":"SMTI","listing_kind":"stock","pathname":"/stocks/smti","exchange":"Nasdaq","country":"US"}}

